10/27
10:07 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at Johnson Rice.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at Johnson Rice.
10/27
10:07 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at Johnson Rice.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at Johnson Rice.
10/27
10:07 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at Johnson Rice.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at Johnson Rice.
10/27
10:07 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/15
08:12 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.